BUSINESSWIRE · 2026-11-05 04:00 UTC

World-First Achievement: SUSMED's Blockchain-Based Clinical Trial System Supports Successful Marketing Authorization for Pharmaceutical Product

SUSMED, Inc. announced its blockchain-based clinical trial system SUSMED SourceDataSync® contributed to obtaining marketing authorization for a pharmaceutical product in Japan. This marks the world's first pharmaceutical approval based on clinical trial results using blockchain technology. The system reduces data entry workload and regulatory monitoring tasks at medical sites, addressing challenges of rising R&D costs and drug lag in pharmaceutical development.

Loading the story on Tree News…